Al Haidari G, Solbakken AM, Åsli LM, Skovlund E, Undseth C, Guren MG(2025) Treatment and outcomes for locally recurrent rectal cancer in Norway Acta Oncol, 64, 784-792 DOI 10.2340/1651-226X.2025.42991, PubMed 40500960
Almhagen E, Alkhiat A, Sorcini B, Alpsten F, Kronborg CJS, Rønde HS, Guren MG, Pilskog S, Valdman A(2025) An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer Cancers (Basel), 17(16) DOI 10.3390/cancers17162627, PubMed 40867256
Ascierto PA, Tang H, Dolfi S, Nyakas M, Marie Svane I, Muñoz-Couselo E, Grob JJ, Gomez-Roca CA, Chiarion-Sileni V, Peltola K, Larkin J, Melero I, Callahan M, Dummer R, Djidel P, Warad D, Reusser-Wolf D, Lipson EJ, Garnett-Benson C(2025) Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020 J Immunother Cancer, 13(2) DOI 10.1136/jitc-2024-009773, PubMed 40010775
